Skip to main content

Advertisement

SpringerLink
Log in

Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

  • Review Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/ recommendations that can be adapted to the Indian Scenario.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Reddy KS (2015) India’s aspirations for Universal Health coverage. N Engl J Med 373(1):1–5

    Article  CAS  PubMed  Google Scholar 

  2. Wadhera RK, Rajkumar SV (2010) Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 85(10):933–942

    Article  PubMed  PubMed Central  Google Scholar 

  3. Meher Lakshmi Konatam AP, Sadashivudu G (2016) Age of onset of multiple myeloma: a Paradigm shift in Indian patients Indian. J Appl Res 6(10):3

    Google Scholar 

  4. Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D et al (2015) Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 65(1):30–54

    Article  PubMed  Google Scholar 

  5. Rajkumar SV (2016) Myeloma today: disease definitions and treatment advances. Am J Hematol 91(1):90–100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Al-Quran SZ, Yang L, Magill JM, Braylan RC, Douglas-Nikitin VK (2007) Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry. Hum Pathol 38(12):1779–1787

    Article  PubMed  PubMed Central  Google Scholar 

  7. Paiva B, Vidriales MB, Perez JJ, Mateo G, Montalban MA, Mateos MV et al (2009) Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients. Haematologica 94(11):1599–1602

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rajan AM, Rajkumar SV (2015) Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer J 5:e365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A et al (2011) Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 117(18):4701–4705

    Article  CAS  PubMed  Google Scholar 

  10. Facon T (2015) Maintenance therapy for multiple myeloma in the era of novel agents. Hematol Am Soc Hematol Educ Prog 2015:279–285

    Google Scholar 

  11. Moreau P, Attal M, Facon T (2015) Frontline therapy of multiple myeloma. Blood 125(20):3076–3084

    Article  CAS  PubMed  Google Scholar 

  12. Gertz MA, Dingli D (2014) How we manage autologous stem cell transplantation for patients with multiple myeloma. Blood 124(6):882–890

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dhakal B, Vesole DH, Hari PN (2016) Allogeneic stem cell transplantation for multiple myeloma: is there a future? Bone Marrow Transp 51(4):492–500

    Article  CAS  Google Scholar 

  14. Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J et al (2003) High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Natl Med J India 16(1):16–21

    PubMed  Google Scholar 

  15. Trivedi M, Martinez S, Corringham S, Medley K, Ball ED (2009) Optimal use of G-CSF administration after hematopoietic SCT. Bone Marrow Transp 43(12):895–908

    Article  CAS  Google Scholar 

  16. Chen C, Rabea AM, Masih-Khan E, Chu C-M, Kukreti V, Trudel S et al (2011) Central Nervous System (CNS) Involvement with Multiple Myeloma (MM)–Longterm Survival Can Be Achieved with Radiation, Intrathecal (IT) Chemotherapy, and Immunomodulatory Agents (IMiDs). Blood. 118(21):3983

    Google Scholar 

  17. Dimopoulos MA, Sonneveld P, Leung N, Merlini G, Ludwig H, Kastritis E et al (2016) International myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment. J Clin Oncol 34(13):1544–1557

    Article  PubMed  Google Scholar 

  18. Silbermann R, Roodman GD (2013) Myeloma bone disease: pathophysiology and management. J Bone Oncol 2(2):59–69

    Article  PubMed  PubMed Central  Google Scholar 

  19. Vesole DH, Oken MM, Heckler C, Greipp PR, Katz MS, Jacobus S et al (2012) Oral antibiotic prophylaxis of early infection in multiple myeloma: a URCC/ECOG randomized phase III study. Leukemia 26(12):2517–2520

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Alemu A, Richards JO, Oaks MK, Thompson MA (2016) Vaccination in multiple myeloma: review of current literature. Clin Lymphoma Myeloma Leuk 16(9):495–502

    Article  PubMed  Google Scholar 

Download references

IMAGE Group

Abhay Bhave, Mumbai; Ajay Sharma, Sir Gangaram Hospital, New Delhi; A.K.Tripathi, KGMU, Lucknow;Alka Khadwal, PGIMER, Chandigarh; Anil Aribandi, American Oncology, Hyderabad; Anita Ramesh, Saveetha Medical College Hospital, Chennai; Ashish Dixit, Manipal Hospital, Bengalaru; Anup J Devasia, CMC Vellore; Charu Batra, Karnal, Chezhian Subash, MIOT, Chennai; Dharma Choudhary, BL Kapoor Hospital, New Delhi, Dinesh Bhurani, Rajiv Gandhi Cancer Center, New Delhi; Deepesh Lad, PGIMER, Chandigarh; Farah Jijina, PD Hinduja Hospital, Mumbai; Gaurav Prakash, PGIMER, Chandigarh; Ganesh Jaishetwar, Yashoda Hospital, Hyderabad; Wg Cdr Harshit Khurana, Command Hospital, Bengalaru; Hemant Malhotra, SMS Jaipur; H.S. Kohli, PGIMER, Chandigarh; Ian Pinto, Reliance Foundation, Mumbai; Javid Rasool, SKIMS, Srinagar, Jatin Sarin, IVY Hospital, Mohali; Jina Bhattacharyya, Medical Collegue, Guwahati; Col Jasjit Singh, Command Hospital, Chandigarh; K Govind Babu, Kidwai Memorial Institute of Oncology; K Pavithran, Amrita Institute, Kochi; Kannan Subramanian, Sahaydari Hospital, Pune; M Joseph John, CMC, Ludhiana; Man Updesh Singh Sachdeva, PGIMER, Chandigarh; Maitreyee Bhattacharyya, MC Kolkata, Kolkata, MB Agarwal, Bombay Hospital, Mumbai; Manju Sengar, TMH, Mumbai, Narender Kumar, PGIMER, Chandigarh; Nitin Sood, Medanta Hospital, New Delhi; Prantar Chakravarti, NRS Medical College, Kolkata, PG Subramanian, TMH, Mumbai; Prashant Sharma, PGIMER, Chandigarh; Prashant Tembhare, TMH, Mumbai; Pravas Mishra, AIIMS, New Delhi, Prasanth Ganesan, Cancer Institute Adiyar, Chennai, Rahul Naithani, Max Hospital, New Delhi; Rayaz Ahmed, RCGI, New Delhi; Ritu Gupta, IRCH, AIIMS, New Delhi; Ritu Bansal, PGIMER, Chandigarh; Ritambhra Nada, PGIMER, Chandigarh; Raman Arora, Oswal Hospital, Ludhiana; Col Rajan Kapoor, Army Hospital (R&R), New Delhi; Reena Das, PGIMER, Chandigarh; Reena Nair, TMC, Kolkata; Sandeep Shah, GCRI, Ahmedabad, Savita Kumari, PGIMER, Chandigarh; Sharat Damodar, Mazumdar Cancer Center, Bengalaru; Sachin Gupta, Max Hospital, Mohali, Sameer Melinkeri, Deenanath Mangeshkar Hospital, Pune; Shano Naseem, PGIMER, Chandigarh, Sreejesh Sreedharanunni, PGIMER, Chandigarh Suparno Chakrabarti, DHRC, New Delhi; Sadashivudu Gundeti, NIMS, Hyderabad; Surg Capt S Das, Army Hospital (R&R) Hospital, New Delhi,Soniya Nityanand, SGPGI, Lucknow; Seema Bhatwadekar, Sterling Hospital, Vadodra; Shankar Prinja, PGIMER, Chandigarh; Tejinder Singh, Onquest Laboratories, New Delhi; Vikas Suri, PGIMER, Chandigarh; Lt Gen Velu Nair, Army Hospital (R&R), New Delhi.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, PGIMER, Chandigarh, 160012, India

    Uday Yanamandra, Arihant Jain, Neelam Varma, Subhash Varma & Pankaj Malhotra

  2. Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India

    Navin Khattry

  3. Mayo Clinic, Rochester, MN, USA

    Shaji Kumar

  4. Massachusetts General Hospital Cancer Center, Boston, USA

    Noopur Raje

  5. The Tisch Cancer Institute, New York, USA

    Sundar Jagannath

  6. Cytecare Hospital, Bengaluru, India

    Hari Menon

  7. Department of Medical Oncology, AIIMS, New Delhi, India

    Lalit Kumar

  8. Prince Aly Khan Hospital, Mumbai, India

    Tapan Saikia

Authors
  1. Uday Yanamandra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Navin Khattry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shaji Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noopur Raje
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arihant Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sundar Jagannath
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hari Menon
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lalit Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Neelam Varma
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Subhash Varma
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tapan Saikia
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Pankaj Malhotra
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for IMAGe Group

  • Abhay Bhave
  • , Ajay Sharma
  • , A. K. Tripathi
  • , Alka Khadwal
  • , Anil Aribandi
  • , Anita Ramesh
  • , Ashish Dixit
  • , Anup J. Devasia
  • , Charu Batra
  • , Chezhian Subash
  • , Dharma Choudhary
  • , Dinesh Bhurani
  • , Deepesh Lad
  • , Farah Jijina
  • , Gaurav Prakash
  • , Ganesh Jaishetwar
  • , Harshit Khurana
  • , Hemant Malhotra
  • , H. S. Kohli
  • , Ian Pinto
  • , Javid Rasool
  • , Jatin Sarin
  • , Jina Bhattacharyya
  • , Col Jasjit Singh
  • , K. Govind Babu
  • , K. Pavithran
  • , Kannan Subramanian
  • , M. Joseph John
  • , Man Updesh Singh Sachdeva
  • , Maitreyee Bhattacharyya
  • , M. B. Agarwal
  • , Manju Sengar
  • , Narender Kumar
  • , Nitin Sood
  • , Prantar Chakravarti
  • , P. G. Subramanian
  • , Prashant Sharma
  • , Prashant Tembhare
  • , Pravas Mishra
  • , Prasanth Ganesan
  • , Rahul Naithani
  • , Rayaz Ahmed
  • , Ritu Gupta
  • , Ritu Bansal
  • , R. Itambhra Nada
  • , Raman Arora
  • , Rajan Kapoor
  • , Reena Das
  • , Reena Nair
  • , Sandeep Shah
  • , Savita Kumari
  • , Sharat Damodar
  • , Sachin Gupta
  • , Sameer Melinkeri
  • , Shano Naseem
  • , Sreejesh Sreedharanunni
  • , Suparno Chakrabarti
  • , Sadashivudu Gundeti
  • , S. R. Das
  • , Soniya Nityanand
  • , Seema Bhatwadekar
  • , Shankar Prinja
  • , Tejinder Singh
  • , Vikas Suri
  •  & Velu Nair

Corresponding author

Correspondence to Pankaj Malhotra.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanamandra, U., Khattry, N., Kumar, S. et al. Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference. Indian J Hematol Blood Transfus 33, 15–21 (2017). https://doi.org/10.1007/s12288-016-0773-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-016-0773-9

Keywords

Search

Navigation